Even though RVX and ZEN are two separate companies, I view success for one as being success for the other....that's how I think the market will react. In terms of RVX success though, if Apabetalone is that "first molecule" that shines a light....if ZEN is still not publicly traded, it will be hard to quantify the impact on Zenith obviously.....

With both companies having basically the same BODs, to my way of thinking.....success breeds success. If Zenith comes out with some moleucle that catches the market's attention, then people are going to see the individuals behind that success and see them sitting on RVX's BOD and are people are gonna say "look....these same successful people that are behind Zenith, they're also behind this other company Resverlogix".

Just my two cents

And SF thanks for reminding me that the cost of owning a sizeable positition in Zenith would mean having paid substantially higher for my RVX shares...which, at least as of right now, are in the black.